Docuvera is a leading software company specializing in AI-powered structured content authoring solutions for the pharmaceutical and life sciences industries. The platform enables organizations to streamline the creation, review, approval, translation, and publication of regulated documents by reusing approved, compliant component content. By replacing document-centric systems with a modular, component-based approach, Docuvera helps life sciences companies improve consistency, reduce cycle times, and ensure regulatory compliance across global markets. In May 2025, Docuvera was acquired by cormeo, a Pharma Tech holding company under Bertelsmann Investments. This acquisition aims to integrate Docuvera's structured content capabilities into cormeo's broader portfolio of life sciences information management solutions, further supporting digital transformation initiatives in the pharmaceutical sector.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Life Sciences Content Management / Pharma Tech
SIZE & FINANCIALS
Employees:51-200
Revenue:$5M-$10M
Founded:2017
Ownership:subsidiary
Status:acquired
FUNDING
Investors:Bertelsmann Investments
0
CORPORATE STRUCTURE
Parent Company:cormeo
Acquired By:cormeo (Bertelsmann Investments) (2025-05-01)
Key Partnerships:Veeva Vault (integration partner), Microsoft SharePoint (integration partner), EXTEDOpulse (integration partner)
COMPETITION
Position:Niche Player
Competitors:Veeva Systems, EXTEDO, ArisGlobal
LINKS
Website:docuvera.com
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Docuvera and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Docuvera. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.